Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: IQV

IQVIA Holdings Inc.

Healthcare | Medical - Diagnostics & Research
$158.13 -4.15 (-2.56%) as of 2026-07-15 04:54 UTC
Market Cap$26.8B
EPS (TTM)$7.84

IQVIA Holdings Inc. (NYSE: IQV) is a $26.8B medical - diagnostics & research company trading at $158.13 (−2.6% today) — 20.2× trailing earnings. Figures from SEC EDGAR and market feeds; updated 2026-07-15 04:54 UTC.

52-Week Range
Low $156.32High $180.98

What IQVIA Holdings Inc. does

IQVIA is a global provider of clinical research services, commercial insights, and healthcare intelligence to life sciences and healthcare companies. The company operates one of the world's largest healthcare information collections, including comprehensive patient records and data from numerous suppliers across many countries, which it processes through advanced analytics and proprietary technology infrastructure.

Summarized from IQVIA Holdings Inc.’s SEC filings · Read the filing ↗

Key facts
Quote
Price$158.13
Change (1D)-4.15 (-2.56%)
Market cap$26.8B
52-week range$156.32 – $180.98
Valuation
P/E (TTM)20.17×
EV/EBITDA11.60×
EPS (TTM)$7.84
Price/book4.05×
Return on equity20.51%
Debt/equity2.09
Returns
52-week return+1.2%
Revenue, margins & earnings
FY2021 Net income: $966MFY2021 Taxes & interest: $427MFY2021 Operating costs: $12.5B$13.9BFY2021FY2022 Net income: $1.09BFY2022 Taxes & interest: $708MFY2022 Operating costs: $12.6B$14.4BFY2022FY2023 Net income: $1.36BFY2023 Taxes & interest: $619MFY2023 Operating costs: $13.0B$15.0BFY2023FY2024 Net income: $1.37BFY2024 Taxes & interest: $829MFY2024 Operating costs: $13.2B$15.4BFY2024FY2025 Net income: $1.36BFY2025 Taxes & interest: $822MFY2025 Operating costs: $14.1B$16.3BFY2025
  • Net income
  • Taxes & interest
  • Operating costs
Annual revenue; bands show net, operating margins · Open in Platform →
SEC Filings SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-05-11
  • 2026-05-11DANHAKL JOHN GA185$33.0K
  • 2026-05-11Fasano JimA228$40.7K
  • 2026-05-11GOGGINS COLLEEN AA214$38.2K
Sign in to see all transactions →
Top Institutional Holders (latest 13F)
Source: SEC EDGAR · As of 2026-Q1
  • VANGUARD GROUP INC19,570,177$4.41B+0.4%
  • HARRIS ASSOCIATES L P12,183,275$2.08B+7.6%
  • BlackRock, Inc.11,632,809$1.98B-17.9%
View QoQ ownership changes →
Company news View all →
Questions this page answers

What does IQVIA Holdings Inc. do?

IQVIA is a global provider of clinical research services, commercial insights, and healthcare intelligence to life sciences and healthcare companies.

What is IQV's valuation?

IQV trades at $158.13, 20.17× trailing earnings, 11.60× EV/EBITDA, as of 2026-07-15.

When did IQV last file with the SEC?

IQVIA Holdings Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-11. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-07-15 04:54 UTC. This page is also available as JSON at /api/data?ticker=IQV and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for IQV and 3,500+ tickers.

Create a free account — keep IQV
For your agent
GET /api/data?ticker=IQV

This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt